Orforglipron- A new ORAL Weight Loss Drug that’s soon to be approved.
Автор: The PharmEZ Tutor
Загружено: 2025-07-21
Просмотров: 284
In this special edition of the PharmEZ tutor, we review orforglipron, an exciting new ORAL weight loss drug that’s soon to be approved by the FDA. One important thing to know: it’s a weight loss drug that can be taken ORALLY. The release of orforglipron may represent a pivotal turning point in managing weight loss and could be the next megahit after Ozempic! Will orforglipron be a game changer in weight loss management?
Topics of discussion include:
• Advantages of orforglipron over current injectable GLP-1 agonists.
• Pharmacology of GLP-1 agonists and of orforglipron.
• Review of phase 2 clinical study of orforglipron in obesity and overweight.
• Review of ACHIEVE-1 trial, a phase 3 clinical study of orforglipron in Type 2 Diabetes
• Comparison of GLP-1 agonists with respect to weight loss.
• Description of future weight loss drugs in the pipeline.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
